ERIC 2018: Dr. Jennifer Brown on Getting the Correct Diagnosis of CLL (chronic lymphocytic leukemia) The European Research Initiative on CLL (ERIC) held their first international meeting, NEW FRONTIERS IN CLL RESEARCH, in Barcelona, Spain Oct.... January 13, 20192018 ConferencesBy Brad Hedrick
ASH 2018: Dr. Stephan Stilgenbauer on the superiority of ibrutinib + rituximab vs FCR for frontline use in CLL (Chronic Lymphocytic Leukemia) in patients under 70 ASH (American Society of Hematology Annual Meeting) is the largest and most important forum for the presentation of new blood... January 8, 20192018 ConferencesBy Brad Hedrick
ASH 2018: Professor Peter Hillmen on the Combination of Ibrutinib and Obinutuzumab in CLL: Timing Matters ASH (American Society of Hematology) Annual Meeting and Exposition is where nearly all the most important blood cancer research is... December 17, 20182018 ConferencesBy Brad Hedrick
ASH 2018: Professor Hillmen on Venetoclax Resistance in CLL By Brian Koffman, MD ASH 2018: Professor Hillmen on Venetoclax Resistance in CLL (chronic lymphocytic leukemia) On the last day of ASH... December 14, 20182018 ConferencesBy Brad Hedrick
ASH 2018 DAY 3 UPDATE My wife, a fellow OSU patient, Wally, and my treatment team from OSU at the CARE CLL HERO Gala I am... December 3, 20182018 ConferencesBy Patty Koffman
ASH 2018 Day 1 Update Day 1 at ASH (American Society of Hematology) Annual Meeting 2018 in San Diego, the world’s largest hematology meeting, is... December 1, 20182018 ConferencesBy Patty Koffman
ASCO 2018: Dr. Davids on the CAPIVATE trial on combining ibrutinib and venetoclax (I+V) frontline in CLL (chronic lymphocytic leukemia) Dr. Matt Davids from Dana Farber presents early but very promising data on the combination of two strong oral targeted... November 30, 20182018 ConferencesBy Brad Hedrick
Prague 2018: CLL Advocates Network (CLLAN) Interview with Jana Pelouchova It was my privilege to be interviewed by Jana Pelouchova who hosted the CLLAN Horizon Meeting in Prague August 31-... October 12, 20182018 ConferencesBy Brad Hedrick
ASCO: 2018: Dr. Pagel on the Important CLL (chronic lymphocytic leukemia) Research Dr. John Pagel out of Swedish Hospital in Seattle reviews the top CLL abstracts presented at ASCO (American Society of... September 24, 20182018 ConferencesBy Brad Hedrick
ASH 2017: Atlanta Professor Michael Hallek on MRD Negativity in CLL By Brian Koffman, MD Dr. Michael Hallek from Cologne (Koeln) leads the German team that does so much important chronic lymphocytic... September 21, 20182017 ConferencesBy Brad Hedrick
